193 related articles for article (PubMed ID: 36215268)
1. Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.
Baek K; Maharjan S; Akauliya M; Thapa B; Kim D; Kim J; Kim M; Kang M; Kim S; Bae JY; Lee KW; Park MS; Lee Y; Kwon HJ
PLoS One; 2022; 17(10):e0275722. PubMed ID: 36215268
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
3. Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.
Budimir N; de Haan A; Meijerhof T; Gostick E; Price DA; Huckriede A; Wilschut J
Influenza Other Respir Viruses; 2013 Nov; 7(6):1202-9. PubMed ID: 24102979
[TBL] [Abstract][Full Text] [Related]
4. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
5. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
[TBL] [Abstract][Full Text] [Related]
6. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.
Lowen AC; Steel J; Mubareka S; Carnero E; García-Sastre A; Palese P
J Virol; 2009 Apr; 83(7):2803-18. PubMed ID: 19153237
[TBL] [Abstract][Full Text] [Related]
7. Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
Shibuya M; Tamiya S; Kawai A; Yoshioka Y
Biochem Biophys Res Commun; 2021 May; 554():166-172. PubMed ID: 33798943
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
Vincent AL; Ma W; Lager KM; Janke BH; Webby RJ; García-Sastre A; Richt JA
Vaccine; 2007 Nov; 25(47):7999-8009. PubMed ID: 17933442
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.
Gautam A; Park BK; Kim TH; Akauliya M; Kim D; Maharjan S; Park J; Kim J; Lee H; Park MS; Lee Y; Kwon HJ
Front Immunol; 2019; 10():1160. PubMed ID: 31191534
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
Kawai A; Yamamoto Y; Nogimori T; Takeshita K; Yamamoto T; Yoshioka Y
J Virol; 2021 Sep; 95(20):e0118021. PubMed ID: 34379511
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on the vaccination of mice with inactivated influenza virus administered by the aerosol technique, by the intranasal or intramuscular route (author's transl)].
Neukirch M; Bauer K; Barth S
Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):409-20. PubMed ID: 44935
[TBL] [Abstract][Full Text] [Related]
13. Intranasal co-administration of 1,8-cineole with influenza vaccine provide cross-protection against influenza virus infection.
Li Y; Xu YL; Lai YN; Liao SH; Liu N; Xu PP
Phytomedicine; 2017 Oct; 34():127-135. PubMed ID: 28899494
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
15. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
16. Sublingual vaccination with influenza virus protects mice against lethal viral infection.
Song JH; Nguyen HH; Cuburu N; Horimoto T; Ko SY; Park SH; Czerkinsky C; Kweon MN
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1644-9. PubMed ID: 18227512
[TBL] [Abstract][Full Text] [Related]
17. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
[TBL] [Abstract][Full Text] [Related]
18. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
[TBL] [Abstract][Full Text] [Related]
19. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
Front Immunol; 2018; 9():934. PubMed ID: 29770135
[TBL] [Abstract][Full Text] [Related]
20. Induction of heterosubtypic immunity to influenza virus by intranasal immunization.
Quan FS; Compans RW; Nguyen HH; Kang SM
J Virol; 2008 Feb; 82(3):1350-9. PubMed ID: 18032492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
